Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Potential complementary evidence of GLP-1RAs and SGLT2is In a meta-analysis comparing the effects of GLP-1RAs with SGLT2is, five GLP-1RA (ELIXA, LEADER, SUSTAIN-6, EXSCEL, and Harmony Outcomes) and three SGLT2i trials (EMPA-REG OUTCOME, CANVAS Program, and DECLARE-TIMI 58) with a total of 77,242 patients were include [35]
Results May Vary: Testimonials and customer experiences represent individual outcomes and may not reflect typical results
Risk ratios (RR), hazard ratios (HR), or mean differences with 95% confidence intervals (CI) are presented accordingly
Any new or concerning cardiac symptoms warrant appropriate clinical evaluation to exclude other causes, regardless of their temporal relationship to medication initiation
US$ 24.08
US$ 23.72
US$ 27.35
US$ 24.01
US$ 24.70
US$ 29.26
